Q2 2024 Balchem Corp Earnings Call Transcript
Key Points
- Balchem Corp (BCPC) reported solid second-quarter financial results with growth in sales and record earnings from operations.
- The human nutrition and health segment delivered strong sales growth and record earnings, driven by high demand for minerals and nutrients.
- Specialty products segment also showed strong sales growth and record earnings, contributing positively to overall performance.
- Gross margin dollars grew by 7.3%, with an expansion of gross margin percentage by 210 basis points to 35.5%.
- The company launched a new product, Optifolin+, which is expected to penetrate the large folic acid market and contribute significantly to future revenue.
- The animal nutrition and health segment experienced a decline in sales by 19.2%, primarily due to lower sales in monogastric and ruminant species markets.
- Earnings from operations in the animal nutrition and health segment decreased by 64.9% from the prior year.
- The company faced increased operating expenses, rising from $35 million to $37 million compared to the prior year.
- The effective tax rate increased slightly from 21.6% to 22.2%, impacting net income.
- Despite strong overall performance, the animal nutrition and health segment continues to face challenges in the broader animal feed additives market.
Greetings, and welcome to Balchem's second-quarter 2024 earnings call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Martin Bengtsson, Chief Financial Officer. Thank you, Martin. You may begin.
Thank you and good morning, everyone. Thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending June 30, 2024. My name is Martin Bengtsson, Chief Financial Officer, and hosting this call with me is Ted Harris, our Chairman, President, and CEO.
Following the advice of our council, auditors, and the SEC, at this time I would like to read our forward-looking statement. Statements made in today's calls that are not historical facts are considered forward-looking statements. We can give no assurance that the expectations reflected in forward-looking statements will prove correct, and various factors could cause actual results to differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |